Search API

older men sitting in the sun

Positive Phase III Study Results Announced in Advanced Prostate Cancer Patients

Novartis 177Lu-PSMA-617 is an investigational PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer
March 23, 2021
mom and daughter talking on a park bench

Advanced Cervical Cancer Monotherapy Study Stopped Early for Positive Results

Regeneron Libtayo is the first immunotherapy to demonstrate improved overall survival in patients with cervical cancer
March 15, 2021
young woman's face thinking hard

Therapeutic HPV16-positive Vaccine Expands Late-stage Study

Transgene TG4001 is a two-pronged antiviral approach for HPV16 positive cancer treatment
March 11, 2021
woman getting a mammogram

Consecutive Mammography Screenings Reduces Risk

Mammography examinations reduce mortality from breast cancer
March 7, 2021
older man smoking a pipe

Innovative Prostate Cancer Treatment Approved by the U.S. FDA

Myovant Sciences Orgovyx is an orally administered treatment that works by blocking the pituitary gland from making hormones
December 19, 2020
older couple riding a bike under a beautiful sky

Universal Cancer Vaccine Candidate Shows Positive Impact

Ultimovacs' UV1 universal cancer vaccine candidate leverages the high prevalence of the human telomerase
December 10, 2020
researcher working in a lab

First Bispecific Immunotherapy Approved in China

BeiGene BLINCYTO immunotherapy demonstrated superior overall survival versus chemotherapy
December 8, 2020
young women hiking in the mountains

Monotherapy Treatment of Advanced HPV16+ Cancers Shows Promising Anti-Tumor Activity

HOOKIPA Pharma HB-201 monotherapy is engineered using a replicating arenaviral vector platform
December 7, 2020
researcher working in a lab

Investigational Irinotecan Liposome Injection Granted FDA Fast Track Designation

Ipsen Onivyde authorized for small cell lung cancer studies
December 5, 2020
older men at a cafe outside

First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer Approved

FDA approved UCLA and CAL’s Gallium 68 PSMA-11 prostate cancer drug
December 3, 2020